In a new study published in Molecular Cancer Research, Mayo Clinic researchers identified critical genomic changes in response to abiraterone acetate/prednisone, a standard treatment option for men with progressive, incurable ...
Sep 22, 2022
0
31
A study conducted by Ludwig Johns Hopkins researchers, their colleagues at Johns Hopkins University and Ludwig alumni at the Walter and Eliza Hall Institute of Medical Research (WEHI), in Melbourne, examined whether circulating ...
Sep 20, 2022
0
64
Immune checkpoint inhibitor (ICI) therapy is a type of treatment for melanoma, the deadliest form of skin cancer, which blocks proteins on tumor or immune cells that prevent the immune system from killing cancer cells.
Sep 19, 2022
0
1486
A single research test has the potential to predict which patients treated with immunotherapies—which harness the immune system to attack cancer cells—are likely to have their cancer recur or have severe side effects, ...
Sep 15, 2022
0
54
Tumors have significant differences depending on the person affected, even if they are the same cancer, such as breast cancer. Therefore, precision oncology targets specific genetic characteristics of a tumor and incorporates ...
Sep 1, 2022
0
4
Breast cancer is categorized into three major subtypes: hormone receptor-positive, HER2-positive, and triple-negative. Although there are targeted therapeutic approaches for the first two, there are limited options for triple ...
Aug 29, 2022
0
37
A new study published today in Blood Advances outlines practical strategies for promoting diversity, equity, inclusion, and access in cancer clinical research. The study highlights significant racial disparities in cancer ...
Aug 25, 2022
0
4
Rice University and Baylor College of Medicine researchers have shown they can eradicate advanced-stage mesothelioma tumors in mice in just a few days with a treatment combining Rice's cytokine "drug factory" implants and ...
Aug 22, 2022
0
177
Despite having lived with five different cancers over the last two decades—prostate, thyroid, kidney, appendix, and skin—Joel Nowak doesn't consider himself a "survivor." Rather, as a self-described "cancer thriver," ...
Aug 22, 2022
0
7
A team led by scientists Dr. Maximilian Kückelhaus and Prof. Tobias Hirsch from the Centre for Musculoskeletal Medicine at the University of Münster has carried out the first completely robot-supported microsurgical operations ...
Aug 19, 2022
0
89
